Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from National Health Investors ( (NHI) ) is now available.
On November 5, 2025, Robert G. Adams, a member of the Board of Directors of National Health Investors, Inc., announced he will not seek reelection at the company’s 2026 annual meeting of stockholders. His decision is not due to any disagreement with the company’s operations or policies. Additionally, Charlotte A. Swafford, another board member, will retire effective May 27, 2026, prior to the 2026 Annual Meeting, also without any disagreements with the company.
The most recent analyst rating on (NHI) stock is a Buy with a $85.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.
Spark’s Take on NHI Stock
According to Spark, TipRanks’ AI Analyst, NHI is a Outperform.
National Health Investors demonstrates strong financial performance and positive earnings call sentiment, driven by strategic acquisitions and growth in the SHOP segment. The company’s fair valuation and attractive dividend yield further enhance its appeal. However, technical indicators suggest caution due to potential overbought conditions and bearish momentum.
To see Spark’s full report on NHI stock, click here.
More about National Health Investors
Average Trading Volume: 209,427
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.56B
For a thorough assessment of NHI stock, go to TipRanks’ Stock Analysis page.